6 sialyllactose - Intrinsic Medicine
Alternative Names: 6-SL; OM-003Latest Information Update: 04 Jan 2023
At a glance
- Originator Intrinsic Medicine
- Class Analgesics; Behavioural disorder therapies; Oligosaccharides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pain; Pervasive child development disorders
Most Recent Events
- 04 Jan 2023 Chemical structure information added
- 28 Nov 2022 Pharmacodynamics data from preclinical study in Pain and Pervasive child development disorders released by Intrinsic Medicine (Intrinsic Medicine pipeline, November 2022)
- 31 Oct 2022 Preclinical trials in Pain in USA (unspecified route) (Intrinsic Medicine website; November 2022)